PIERUZZI FEDERICO UMBERTO EMILIO GUGLIE

Camporeale, A., De Angeli, G., Guida, G., Pieruzzi, F., Econimo, L., Lusardi, P., et al. (2026). Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD). INTERNATIONAL JOURNAL OF CARDIOLOGY, 444(February 01, 2026) [10.1016/j.ijcard.2025.134011]. Dettaglio

Lanfranconi, F., Peli, L., Pollastri, L., Ferri, A., Tremolizzo, L., Conti, E., et al. (2026). Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type III. PHYSIOLOGICAL REPORTS, 14(4 (February 2026)) [10.14814/phy2.70771]. Dettaglio

Cazzaniga, G., Carbone, M., Barretta, R., Casati, G., Vatrano, S., Gambaro, G., et al. (2026). Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy. SCIENTIFIC REPORTS, 16(1) [10.1038/s41598-026-35466-w]. Dettaglio

Fabbrini, P., Pieruzzi, F., Bellocchio, F., Casana Eslava, R., Silvestre Llopis, J., Morillo Navarro, K., et al. (2025). The prognostic reasoning system for chronic kidney disease progression (PROGRES-CKD) may help improve waiting list management for outpatient nephrology services in a second-level public hospital in Italy. JN. JOURNAL OF NEPHROLOGY, 38(4), 1219-1227 [10.1007/s40620-025-02222-8]. Dettaglio

Mignani, R., Biagini, E., Cianci, V., Pieruzzi, F., Pisani, A., Tuttolomondo, A., et al. (2025). Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice. ADVANCES IN THERAPY, 42(2), 597-635 [10.1007/s12325-024-03041-2]. Dettaglio